Cargando…
“ADR PvPI” Android mobile app: Report adverse drug reaction at any time anywhere in India
BACKGROUND: To improve the public health and promote instant adverse drug reaction (ADR) reporting, a need to develop an ADR Pharmacovigilance Programme of India (PvPI) mobile app was identified by the National Coordination CentrePvPI (NCCPvPI) to serve the Pan India ADR reporting. The objective of...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759532/ https://www.ncbi.nlm.nih.gov/pubmed/31571709 http://dx.doi.org/10.4103/ijp.IJP_595_18 |
_version_ | 1783453709778288640 |
---|---|
author | Prakash, Jai Joshi, Kalpana Malik, Deepak Mishra, Omkar Sachan, Akhilesh Kumar, Bharat Bhushan, Shashi Kalaiselvan, Vivekanandan Singh, Gyanendra Nath |
author_facet | Prakash, Jai Joshi, Kalpana Malik, Deepak Mishra, Omkar Sachan, Akhilesh Kumar, Bharat Bhushan, Shashi Kalaiselvan, Vivekanandan Singh, Gyanendra Nath |
author_sort | Prakash, Jai |
collection | PubMed |
description | BACKGROUND: To improve the public health and promote instant adverse drug reaction (ADR) reporting, a need to develop an ADR Pharmacovigilance Programme of India (PvPI) mobile app was identified by the National Coordination CentrePvPI (NCCPvPI) to serve the Pan India ADR reporting. The objective of this study was to develop an indigenous Googlebased Android mobile application known as “ADR PvPI” and to analyze the ADRrelated data reported through this mobile application on pilot basis. MATERIALS AND METHODS: The ADR PvPI mobile application was indigenously developed by NCCPvPI officials within 6 months. The study of spontaneous ADR reporting was carried out between September 2017 and September 2018. This article provides an overview of the salient features of ADR PvPI mobile application, guides on how to fillin ADRs, reporting trends of ADR, types of ADR as per System Organ Class and pharmacological classes of drugs. RESULTS: Till date, >5500 users have downloaded the app with an average rating of 4.26. In that tenure, 262 reports have been received through ADR PvPI mobile app. During the year 2017, 3.55% of reports were received through ADR PvPI mobile app and the percentage of reports received by 2018 was 96.45%. CONCLUSION: The frequency of ADR reporting has significantly increased over the past 1 year and should be promoted further through awareness and training programs. |
format | Online Article Text |
id | pubmed-6759532 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-67595322019-09-30 “ADR PvPI” Android mobile app: Report adverse drug reaction at any time anywhere in India Prakash, Jai Joshi, Kalpana Malik, Deepak Mishra, Omkar Sachan, Akhilesh Kumar, Bharat Bhushan, Shashi Kalaiselvan, Vivekanandan Singh, Gyanendra Nath Indian J Pharmacol Educational Forum BACKGROUND: To improve the public health and promote instant adverse drug reaction (ADR) reporting, a need to develop an ADR Pharmacovigilance Programme of India (PvPI) mobile app was identified by the National Coordination CentrePvPI (NCCPvPI) to serve the Pan India ADR reporting. The objective of this study was to develop an indigenous Googlebased Android mobile application known as “ADR PvPI” and to analyze the ADRrelated data reported through this mobile application on pilot basis. MATERIALS AND METHODS: The ADR PvPI mobile application was indigenously developed by NCCPvPI officials within 6 months. The study of spontaneous ADR reporting was carried out between September 2017 and September 2018. This article provides an overview of the salient features of ADR PvPI mobile application, guides on how to fillin ADRs, reporting trends of ADR, types of ADR as per System Organ Class and pharmacological classes of drugs. RESULTS: Till date, >5500 users have downloaded the app with an average rating of 4.26. In that tenure, 262 reports have been received through ADR PvPI mobile app. During the year 2017, 3.55% of reports were received through ADR PvPI mobile app and the percentage of reports received by 2018 was 96.45%. CONCLUSION: The frequency of ADR reporting has significantly increased over the past 1 year and should be promoted further through awareness and training programs. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6759532/ /pubmed/31571709 http://dx.doi.org/10.4103/ijp.IJP_595_18 Text en Copyright: © 2019 Indian Journal of Pharmacology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Educational Forum Prakash, Jai Joshi, Kalpana Malik, Deepak Mishra, Omkar Sachan, Akhilesh Kumar, Bharat Bhushan, Shashi Kalaiselvan, Vivekanandan Singh, Gyanendra Nath “ADR PvPI” Android mobile app: Report adverse drug reaction at any time anywhere in India |
title | “ADR PvPI” Android mobile app: Report adverse drug reaction at any time anywhere in India |
title_full | “ADR PvPI” Android mobile app: Report adverse drug reaction at any time anywhere in India |
title_fullStr | “ADR PvPI” Android mobile app: Report adverse drug reaction at any time anywhere in India |
title_full_unstemmed | “ADR PvPI” Android mobile app: Report adverse drug reaction at any time anywhere in India |
title_short | “ADR PvPI” Android mobile app: Report adverse drug reaction at any time anywhere in India |
title_sort | “adr pvpi” android mobile app: report adverse drug reaction at any time anywhere in india |
topic | Educational Forum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759532/ https://www.ncbi.nlm.nih.gov/pubmed/31571709 http://dx.doi.org/10.4103/ijp.IJP_595_18 |
work_keys_str_mv | AT prakashjai adrpvpiandroidmobileappreportadversedrugreactionatanytimeanywhereinindia AT joshikalpana adrpvpiandroidmobileappreportadversedrugreactionatanytimeanywhereinindia AT malikdeepak adrpvpiandroidmobileappreportadversedrugreactionatanytimeanywhereinindia AT mishraomkar adrpvpiandroidmobileappreportadversedrugreactionatanytimeanywhereinindia AT sachanakhilesh adrpvpiandroidmobileappreportadversedrugreactionatanytimeanywhereinindia AT kumarbharat adrpvpiandroidmobileappreportadversedrugreactionatanytimeanywhereinindia AT bhushanshashi adrpvpiandroidmobileappreportadversedrugreactionatanytimeanywhereinindia AT kalaiselvanvivekanandan adrpvpiandroidmobileappreportadversedrugreactionatanytimeanywhereinindia AT singhgyanendranath adrpvpiandroidmobileappreportadversedrugreactionatanytimeanywhereinindia |